Position in VTRS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$8,920,971
+$1,402,670 QoQ
Shares Held
561,774
+0.9% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#22
of 512 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NEW YORK STATE COMMON RETIREMENT FUND holds $179,041,089 across 40 Drug Manufacturers - Specialty & Generic names. VTRS ranks #8 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,474 | $29,574,387 | |
| 2 | ZTS |
Zoetis Inc.
|
247,049 | $17,752,941 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
272,579 | $17,431,427 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
945,445 | $16,365,652 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
127,334 | $14,126,433 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
154,995 | $12,830,486 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
20,520 | $11,118,351 | |
| 8 | VTRS |
Viatris Inc
This page
|
561,774 | $8,920,971 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,920,971 | 561,774 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $7,518,301 | 556,499 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $7,589,507 | 609,599 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,930,090 | 598,999 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $5,438,361 | 608,999 | Shares | Sole | 2025-10-08 | |
| 2025-03-31 | $5,304,381 | 608,999 | Shares | Sole | 2025-10-08 | |
| 2024-12-31 | $7,728,038 | 620,726 | Shares | Sole | 2025-10-08 | |
| 2024-09-30 | $7,676,833 | 661,226 | Shares | Sole | 2025-10-08 | |
| 2024-06-30 | $8,139,380 | 765,699 | Shares | Sole | 2025-10-08 | |
| 2024-03-31 | $9,205,381 | 770,970 | Shares | Sole | 2025-10-08 | |
| 2023-12-31 | $9,737,404 | 899,114 | Shares | Sole | 2025-10-08 | |
| 2023-09-30 | $9,865,768 | 1,000,585 | Shares | Sole | 2025-10-08 | |
| 2023-06-30 | $11,810,022 | 1,183,369 | Shares | Sole | 2025-10-08 | |
| 2023-03-31 | $11,918,968 | 1,238,978 | Shares | Sole | 2025-10-08 | |
| 2022-12-31 | $14,651,042 | 1,316,356 | Shares | Sole | 2025-10-08 | |
| 2022-09-30 | $11,042,720 | 1,296,094 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $14,248,162 | 1,360,856 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $15,765,816 | 1,449,064 | Shares | Sole | 2022-07-01 | |
| 2021-12-31 | $19,394,916 | 1,433,475 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $32,370,191 | 2,388,944 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $33,276,479 | 2,328,655 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $31,410,525 | 2,248,427 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $45,904,210 | 2,449,531 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||